insights_auto
Kwa nini ALMKT imepungua kwa 4.22%?
Fahamu zaidichevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€ 0.089
arrow_downward
-4.22%(-0.0039) Siku 1
18 Nov, 17:35:09 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
17.68M
Wastani wa kiasi cha mauzo
elfu 481.42
Kiasi cha mauzo ya hisa
elfu 152.44
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.75
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
17.68M
Wastani wa kiasi cha mauzo
elfu 481.42
Kiasi cha mauzo ya hisa
elfu 152.44
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.75
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Yahoo Finance
·
saa 1 iliyopita
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
Barron's
·
saa 5 zilizopita
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
The Motley Fool
·
saa 1 iliyopita
The S&P 500 Just Ended a Run of 155 Trading Days Above Its 200-Day Average. Here's What Followed 34 Similar Runs Since 1950.
Hedgeye
·
saa 15 zilizopita
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com